This dual peptide blend pairs CJC-1295 (No DAC), also known as Modified GRF (1-29), with Ipamorelin two growth hormone secretagogues that act on complementary pathways in a single lyophilised vial containing 5mg of each
People need support to keep weight off after treatment ends
A provider may consider: IGF-1 Fasting glucose A1C Lipids Thyroid markers Liver and kidney markers Blood pressure Sleep quality Current medications Personal and family health history Lab review helps determine whether growth hormone support is appropriate, whether a safer alternative should be considered, and how treatment should be monitored over time
Identification and characterization of membrane androgen receptors in the ZIP9 zinc transporter subfamily: I
Meta-analysis of randomized controlled trials of red meat consumption in comparison with various comparison diets on cardiovascular risk Factors
A healthcare provider may recommend transitioning from one medication to the other if weight loss slows, side effects occur, or another treatment may work better